Pulmatrix and Cullgen Announce Proposed Merger
In 2023 Cullgen completed a Series C financing led by AstraZeneca-CICC Venture Capital Partnership, and also announced a strategic partnership with Astellas Pharma Inc.
Hosted on MSN50m
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
Subscribe here to receive future editions. AstraZeneca said it is doubling down on its investment in its U.S. business, a ...